Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation...

Area of Science:

• Nephrology
• Oxidative Stress Research
• Molecular Biology

Background:

• Diabetic kidney disease (DKD) is characterized by intrarenal oxidative stress from reactive oxygen species (ROS).
• NADPH oxidase enzymes, particularly NOX5, contribute significantly to renal ROS production in DKD.
• Endothelial dysfunction and inflammation, driven by ROS, exacerbate DKD progression, leading to albuminuria and fibrosis.

Purpose of the Study:

• To investigate the role of endothelial cell-specific human NOX5 in DKD pathogenesis using a transgenic mouse model.
• To compare the contribution of NOX5 with NOX4 in the development of DKD.
• To elucidate the mechanisms by which NOX5 exacerbates renal injury, including its impact on endothelial mesenchymal transition (EMT).

Main Methods:

• Generation of a transgenic mouse model expressing human NOX5 specifically in endothelial cells.
• Induction of DKD in these mice to study the effects of NOX5 expression.
• Assessment of renal pathology, including injury, albuminuria, and fibrosis.
• Analysis of ROS formation, endothelial cell dysfunction, and EMT pathway activation.

Main Results:

• Endothelial-specific NOX5 expression significantly exacerbated renal injury, albuminuria, and fibrosis in the DKD mouse model.
• NOX5's detrimental effects were observed independently of the NOX4 pathway.
• Enhanced ROS production and activation of the endothelial mesenchymal transition (EMT) pathway were identified as key mechanisms mediating NOX5-induced renal damage.

Conclusions:

• Endothelial NOX5 plays a critical role in exacerbating renal pathology in DKD.
• NOX5 contributes to DKD progression through ROS generation and promotion of EMT.
• Targeting NOX5, potentially through specific inhibitors, represents a promising therapeutic strategy for managing human DKD.